Skip to content

Drug Discovery through Gene Regulation

The Illumina Genomics Podcast

Drug Discovery through Gene Regulation

Feb 06, 2020 | Episode 59 | 24 mins

Targeted drug discovery has traditionally focused on inhibiting or modulating the function of abnormal proteins. But many more diseases could potentially be treated by controlling the expression of abnormal and normal genes. Listen to Dr. Eric R. Olson of Syros Pharmaceuticals explain how epigenomics is enabling a paradigm shift in drug discovery.

Download or subscribe to our recurring podcasts.